LANADELUMAB-FLYO vs LAROTRECTINIB: Which Drug Is Safer?
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
LANADELUMAB-FLYO vs LAROTRECTINIB: Safety Overview
| Metric | LANADELUMAB-FLYO | LAROTRECTINIB |
|---|---|---|
| Total FAERS Reports | 1,493 | 798 |
| Deaths Reported | 35 | 149 |
| Death Rate | 2.3% | 18.7% |
| Hospitalizations | 427 | 151 |
| Average Patient Age | 45.0 yrs | 48.9 yrs |
| % Female Patients | 77.3% | 51.5% |
| FDA Approval Date | N/A | Nov 26, 2018 |
| Manufacturer | N/A | Bayer HealthCare Pharmaceuticals Inc. |
| Route | N/A | ORAL |
| Marketing Status | Prescription | Prescription |